GC Green Cross Wellbeing Successfully Concludes "Pain Management Symposium"

GC Green Cross Wellbeing announced on the 15th that it successfully concluded the "Pain Management Symposium" on the 13th at Dragon City in Yongsan-gu, Seoul.

At the Pain Management Symposium hosted by GC Green Cross Wellbeing on the 13th, Kim Wanho, director of Kim Wanho Orthopedic Clinic (from left in the photo), Chae Sanghan, director of Songdo Joint Rehabilitation Medicine Clinic, Son Munho, director of Son Orthopedic Clinic, Jung Hoechang, director of Hanbit Anesthesia and Pain Medicine Clinic, and Choi Sehwan, director of Seoul St. Mary's Neurosurgery Clinic, are taking a commemorative photo. Photo by GC Green Cross Wellbeing

This symposium was chaired by Choi Sehwahn, director of Seoul St. Mary's Neurosurgery Clinic, and Kim Wanho, director of Kim Wanho Orthopedic Clinic. The event provided an in-depth discussion on pain treatment strategies that can be applied in real clinical settings.

The main sessions included: "Latest Insights and Clinical Experiences with PDRN and Collagen Injection Therapy for Musculoskeletal Disorders" by Chae Sanghan, director of Songdo Joint Rehabilitation Medicine Clinic; "Current Status of PRP (Platelet-Rich Plasma) as a New Medical Technology and Case Sharing" by Son Munho, director of Son Orthopedic Clinic; and "Pain Treatment Using Laennec Injection (Hydrolyzed Human Placenta Extract)" by Jung Hoechang, director of Hanbit Anesthesia and Pain Medicine Clinic.

In the first lecture, Chae Sanghan, director of Songdo Joint Rehabilitation Medicine Clinic, presented on "Latest Insights and Clinical Experiences with PDRN and Collagen Injection Therapy for Musculoskeletal Disorders." Based on actual clinical cases and the latest research findings, Dr. Chae offered a balanced overview of various therapeutic approaches and precautions for patients with joint disorders, receiving a highly positive response from participants.

Next, Son Munho, director of Son Orthopedic Clinic, delivered a presentation on "Current Status of PRP (Platelet-Rich Plasma) as a New Medical Technology and Case Sharing," explaining the latest designations of new medical technologies and vividly sharing real-world applications and treatment outcomes, which drew significant interest from the attendees.

In the third lecture, Jung Hoechang, director of Hanbit Anesthesia and Pain Medicine Clinic, gave an in-depth presentation on "Pain Treatment Using Laennec Injection (Hydrolyzed Human Placenta Extract)" and shared practical clinical techniques that can be applied in pain management.

One of the medical professionals who attended the symposium commented, "It was a meaningful occasion where I could learn about the latest insights and real-world treatment experiences, and it presented new possibilities for healthcare professionals."

Han Jeongyeop, head of the IP Division at GC Green Cross Wellbeing, stated, "Pain treatment is an important first step in improving patients' quality of life. I hope this symposium will be beneficial to many medical professionals dedicated to pain management, and we will continue to closely collaborate with major departments involved in pain care to provide successful solutions."

This content was produced with the assistance of AI translation services.